/
/
/

Transgene Biotek Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2.85
Volume (₹)5,636.00
High (₹)2.85
Upper Circuit3.43
Low (₹)2.72
Lower Circuit2.29
Prev Close2.86
52W High (₹)4.50
Price2.77
52W Low (₹)1.83

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.99 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity1.45
Price to Book2.53
Book Value1.32
EPS (TTM)-0.21
Face Value10.00
ROE (%)-6.52

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SAGILITY-ANSE
SYNGENE-ANSE
INDGN-ANSE
IGIL-ANSE
NESCO-ANSE
JUSTDIAL-ANSE
LATENTVIEW-ANSE
CMSINFO-ANSE
MEDIASSIST-ANSE
AWFIS-ANSE
TRABI-XNSE
LTP
1W Low
1W High
Market cap (₹)
45.15+0.1 (0.22%)
43.52
46.95
20,865Cr
383.55-2.9 (-0.75%)
374.75
395
15,509Cr
583.45-3.05 (-0.52%)
570.60
605.25
13,904Cr
316+4.65 (1.49%)
307.50
329.55
13,479Cr
1102.75+4.2 (0.38%)
1045.10
1138
7,691Cr
669-6.3 (-0.93%)
656.20
715
5,677Cr
253.05-7.2 (-2.77%)
251.75
267.85
5,300Cr
224.55-6.65 (-2.88%)
223.85
243.50
3,642Cr
316.7-11.3 (-3.45%)
311.95
343.30
2,417Cr
292.2+38.55 (15.20%)
244.45
299
1,788Cr
2.77+0 (0.00%)
2.62
2.92
22Cr

Key Highlights of Transgene Biotek Ltd Balance Sheet

Transgene Biotek Ltd balance sheet discloses shareholders' funds of ₹75.77Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹75.77Cr, and the reserves and surplus of the company is -₹83.32Cr.

The company has its non-current liabilities with total liabilities of ₹34.2Cr as of 2025-03-31.

The current liabilities are ₹12.62Cr as of 2025-03-31. At the same time, current assets are ₹1.26Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹9.5Lakh and tangible assets of ₹7.96Cr, provided in the Transgene Biotek Ltd financial statements.